RxDoctor Payments Data

Bayani Abordo, MD

Psychiatry · Mobile, ALNPI 1881696540

Payments from drug & device makers

$3,750in general payments, 2019–2025

Across 216 payments — averaging $17.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$819
  • AbbVie$796
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$415
  • Takeda Pharmaceuticals U.S.A., Inc.$360
  • Lundbeck LLC$311
  • Johnson & Johnson$182
  • plus $868 from 20 others

What the payments were for

  • Food & beverage$3,750100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,750 in reported general payments places this provider in the 80th percentile of 400 psychiatry providers in Alabama.

See all psychiatry providers in Alabama

Medicare billing

Part B allowed, 2024
$32,629
Medicare patients
50
Services billed
361

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl14$20,254
Quetiapine Fumarate ErQuetiapine Fumarate16$8,905
Aripiprazole65$4,941
Venlafaxine Hcl ErVenlafaxine Hcl52$4,871
Vilazodone Hcl27$4,010
Bupropion XlBupropion Hcl102$3,207
Doxepin Hcl56$2,368
Trazodone Hcl137$2,302
Ziprasidone Hcl14$1,929
Fluoxetine Hcl53$1,844
Hydroxyzine Hcl79$1,721
Lamotrigine ErLamotrigine14$1,550
Duloxetine Hcl51$1,443
Quetiapine Fumarate69$1,285
Desvenlafaxine Succinate ErDesvenlafaxine Succinate16$1,242

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$796$20,25414 claims
Almatica Pharma LLCSertraline Hcl$92$75044 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 400 psychiatry providers in Alabama.

Other psychiatry in Mobile

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →